Skip to main content
OpenTrials
Completed

NCT Number: NCT04769219

Secondary Prevention Education After Acute Myocardial Infarction

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Abant İzzet Baysal University

Merkez, Bolu, 14100, Turkey (Türkiye)

About this study

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.The population of the study will be the individuals hospitalized with the diagnosis of acute myocardial infarction in the Coronary Intensive Care Unit of Abant Izzet Baysal University Izzet Baysal Training and Research Hospital. The study will be conducted in a randomized controlled manner with two groups, 43 in the control group and 43 in the secondary prevention education group. CAG (Coronary Angiography) Procedure Training Form, Patient Identification Form, Physiological Parameters Form and Visual Analogue Scale, Spielberg State and Trait Anxiety Scale and Myocardial Infarction Dimensional Assessment Scale will be used to collect data. The data will be collected by face to face interview technique. For descriptive statistics, mean and standard deviation or median and minimum-maximum values for numerical variables, number and percentage values for categorical variables will be given. The Kolmogorov-Smirnov test (p <0.05), skewness and kurtosis coefficients (should be ± 1) and X ̅ / SS <4 inequalities will be examined at the same time, and the weight in which group will be preferred.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • First time AMI and inpatient treatment in the coronary intensive care unit,
  • Not having received training after AMI *
  • Being 18 years or older,
  • Speak Turkish,
  • No problem in verbal communication,
  • Absence of hearing loss,
  • Not being diagnosed with a psychiatric illness,
  • Being conscious,
  • Being volunteer to participate in the study,
  • Routine check of cholesterol, HDL, LDL, triglyceride results at the beginning of the study and at 6 months.

Exclusion criteria

Not having had AMI for the first time

  • Having received training after AMI
  • Not willing to participate in the study,
  • Cannot speak Turkish,
  • Problems in verbal communication,
  • Having hearing loss,
  • Having a diagnosis of psychiatric illness,
  • Unconsciousness.
  • Cholesterol, HDL, LDL, triglyceride results were not routinely checked at the start and 6 months of the study.

Treatment and study plan

Secondary prevention training

Other

Secondary prevention training will be given after acute myocardial infarction

Primary outcomes

  1. means of subjective anxiety scores

    Time frame: six months

    Spielberg State- Trait Anxiety Scale. The total score between 0-19 obtained from the state anxiety scale shows that there is no anxiety, the total score between 20-39 indicates mild, the average score between 40-59 indicates moderate, and the total score between 60-79 indicates severe anxiety, and over 60 points are needed for professional help. The scores obtained from the trait anxiety scale vary between 20 and 80. A high score means a high and a low level means anxiety

  2. means of subjective quality of life scores

    Time frame: six months

    It consists of 35 items and the quality of life is based on physical activity (12 items), insecurity (9 items), emotional response (4 items), addiction (3 items), diet (3 items), concerns about medication (2 items), Each sub-dimension of MIDAS, which measures seven domains as (2 items), is scored between 0-100. High scores indicate poor health.

Secondary outcomes

  1. means of subjective pain score

    Time frame: six months

    visual analog scale. It consists of a straight line with endpoints that define end limits such as "no pain" and "pain as bad as possible". The patient is asked to mark the level of pain on the line between the two endpoints.

Other outcomes

  1. means of blood pressure (mmHg)

    Time frame: six months

    In the study, a digital sphygmomanometer, which has been calibrated in comparison with the mercury sphygmomanometer, is used in order to prevent individual differences in the measurement of blood pressure. For accurate results, the sphygmomanometer sleeve is sized for adult individuals (width = about 20 cm, length = about 40 cm). In order for the blood pressure not to be affected by the conditions during the measurement, it is taken into account that the individual did not drink tea or coffee, take caffeine, and preferably did not eat during the 30 minutes prior to measurement.

  2. means of total cholesterol (mg/dl)

    Time frame: six months

    The values measured during routine blood checks will be taken for cholesterol values in this study.

  3. means of HDL cholesterol (mg/dl)

    Time frame: six months

    The values measured during routine blood checks will be taken for cholesterol values in this study.

  4. means of LDL cholesterol (mg/dl)

    Time frame: six months

    The values measured during routine blood checks will be taken for cholesterol values in this study.

  5. means of triglyceride (mg/dl)

    Time frame: six months

    The values measured during routine blood checks will be taken for cholesterol values in this study.

Sponsors and collaborators

Lead sponsor

Abant Izzet Baysal University

Other

Registry information

Official study title

The Effect of Secondary Prevention Education Given to Individuals After Acute Myocardial Infarction on Physiological Parameters, Anxiety and Quality of Life

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Feb 24, 2021
Registry last updated
Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.